EKR Therapeutics Overview

  • Founded
  • 2006

Founded
  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $150M

EKR Therapeutics General Information

Description

Developer of prescription products intended to serve the needs of the acute-care hospital setting. The company's products support the life of cancer patients, offer short-term treatment of hypertension and management of various AMI related conditions, enabling patients to get access to preferred treatment at a cost effective manner.

Contact Information

Website
www.ekrtx.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Pharmaceuticals
Other Industries
Therapeutic Devices
Primary Office
  • Third Floor
  • Bedminster Township
  • NJ 07921
  • United States
+1 (877) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

EKR Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Merger/Acquisition 27-Jun-2012 $150M 00000 00000 Completed Generating Revenue
4. Later Stage VC (Series D) 10-Mar-2008 00000 00000 Completed Startup
3. Later Stage VC (Series C) 22-Aug-2007 000.00 000.00 Completed Startup
2. Early Stage VC (Series B) 15-Nov-2006 $7.33M $7.33M Completed Startup
1. Early Stage VC (Series A) 27-Jun-2006 Completed Startup
To view EKR Therapeutics’s complete valuation and funding history, request access »

EKR Therapeutics Patents

EKR Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2007237903-A1 Pre-mixed, ready-to-use iv bolus compositions and methods of use Inactive 18-Apr-2006 000000000
AU-2007240820-A1 Pre-mixed, ready-to-use pharmaceutical compositions Inactive 18-Apr-2006 000000000
CA-2650922-A1 Pre-mixed, ready-to-use pharmaceutical compositions Active 18-Apr-2006 000000000
CA-2650922-C Pre-mixed, ready-to-use pharmaceutical compositions Active 18-Apr-2006 000000000
CA-2649779-A1 Pre-mixed, ready-to-use iv bolus compositions and methods of use Inactive 18-Apr-2006 A61K47/02
To view EKR Therapeutics’s complete patent history, request access »

EKR Therapeutics Former Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Commerce Health Ventures Venture Capital Minority 000 0000 000000 0
ESP Equity Partners PE/Buyout Minority 000 0000 000000 0
Garden State Life Sciences Venture Fund Venture Capital Minority 000 0000 000000 0
LLR Partners Growth/Expansion Minority 000 0000 000000 0
MPM Capital Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 10 investors. Get the full list »